Rujia Xie, Ph.D.
Senior Consultant
Bio
- Joined Pharmetheus in 2024, actively working in client projects
- Expertise includes pharmacometrics in early and late phase projects in therapeutic areas such as infectious, neuropathic pain, inflammation & immunology, and pediatric drug development
- Previously worked as Director in Pharmacometrics at Pfizer Singapore, where she led MIDD strategy, performed analyses, and supported filings for Pfizer global projects, as Head of Pharmacometrics at Pfizer China R&D, as Associate Director/Manager in Pharmacometrics at Pfizer, UK, and as Associate Professor/Assistant Professor/Teaching Assistant at China Pharmaceutical University, China
- B.Sc in Pharmacy (1983) from Nanjing University of TCM, China, and Ph.D. in Pharmacokinetics (2000) from Uppsala University, Sweden